From the Foothills Medical Centre, Department of Clinical Neurosciences (M.H., E.T., K.T., A.A.S., P.O., K.H., A. Bobyn, A.N., N.S., B.K.M., A.M.D.), University of Calgary, Calgary, Alberta, Canada.
Department of Neurology (L.K.), University Ostrava, Ostrava, Czech Republic.
AJNR Am J Neuroradiol. 2024 Jun 7;45(6):693-700. doi: 10.3174/ajnr.A8254.
The presence of spot sign is associated with a high risk of hematoma growth. Our aim was to investigate the timing of the appearance, volume, and leakage rate of the spot sign for predicting hematoma growth in acute intracerebral hemorrhage using multiphase CTA.
In this single-center retrospective study, multiphase CTA in 3 phases was performed in acute intracerebral hemorrhage (defined as intraparenchymal ± intraventricular hemorrhages). Phases of the spot sign first appearance, spot sign volumes (microliter), and leakage rates among phases (microliter/second) were measured. Associations between baseline clinical and imaging variables including spot sign volume parameters (volume and leakage rate divided by median) and hematoma growth (>6 mL) were investigated using regression models. Receiver operating characteristic analysis was used as appropriate.
Two hundred seventeen patients (131 men; median age, 70 years) were included. The spot sign was detected in 21.7%, 30.0%, and 29.0% in the first, second, and third phases, respectively, with median volumes of 19.7, 31.4, and 34.8 μl in these phases. Hematoma growth was seen in 44 patients (20.3%). By means of modeling, the following variables, namely the spot sign appearing in the first phase, first phase spot sign volume, spot sign appearing in the second or third phase, and spot sign positive and negative leakage rates, were associated with hematoma growth. Among patients with a spot sign, the absolute leakage rate accounting for both positive and negative leakage rates was also associated with hematoma growth (per 1-μl/s increase; OR, 1.26; 95% CI, 1.04-1.52). Other hematoma growth predictors were stroke history, baseline NIHSS score, onset-to-imaging time, and baseline hematoma volume (all values < .05).
The timing of the appearance of the spot sign, volume, and leakage rate were all associated with hematoma growth. Development of automated software to generate these spot sign volumetric parameters would be an important next step to maximize the potential of temporal intracerebral hemorrhage imaging such as multiphase CTA for identifying those most at risk of hematoma growth.
斑点征的出现与血肿增大的风险相关。我们旨在使用多期 CTA 研究急性脑出血中斑点征的出现时间、体积和渗漏率,以预测血肿增大。
这项单中心回顾性研究对急性脑出血(定义为脑实质内±脑室内出血)进行了多期 CTA。测量斑点征首次出现的相位、斑点征体积(微升)和各相位之间的渗漏率(微升/秒)。使用回归模型研究了基线临床和影像学变量(包括斑点征体积参数[体积和渗漏率除以中位数])与血肿增大(>6 毫升)之间的关系。适当使用受试者工作特征分析。
共纳入 217 例患者(131 例男性;中位年龄 70 岁)。斑点征分别在第一、第二和第三相位的检出率为 21.7%、30.0%和 29.0%,这些相位的斑点征体积中位数分别为 19.7、31.4 和 34.8 微升。44 例患者出现血肿增大(20.3%)。通过建模,以下变量与血肿增大相关,包括第一相位斑点征出现、第一相位斑点征体积、第二或第三相位斑点征出现,以及斑点征阳性和阴性渗漏率。在有斑点征的患者中,阳性和阴性渗漏率之和的绝对渗漏率也与血肿增大相关(每增加 1 微升/秒;比值比,1.26;95%置信区间,1.04-1.52)。其他血肿增大的预测因子包括卒中史、基线 NIHSS 评分、发病至影像学时间和基线血肿体积(所有 值均<0.05)。
斑点征的出现时间、体积和渗漏率均与血肿增大相关。开发自动生成这些斑点征体积参数的软件将是下一步的重要步骤,以最大限度地发挥多期 CTA 等时间性脑出血成像识别血肿增大高危人群的潜力。